We have identi®ed a novel p53 regulated gene designated DDA3 through dierential mRNA display on IW32 erythroleukemia cells containing a temperature sensitive p53 allele, tsp53val-135. DDA3 mRNA induction could be observed in all sublines expressing tsp53val-135 cultured at permissive temperature as well as in NIH3T3 cells undergoing DNA damage. Upregulation of DDA3 could be detected within 2 h after down-shifting the temperature to 32.58C; upon shifting back to 38.58C, DDA3 mRNA rapidly degraded with a half-life of less than 2 h. Actinomycin D, but not cycloheximide, inhibited the p53 dependent DDA3 induction, suggesting that the activation is through transcriptional regulation and does not require de novo protein synthesis. DDA3 was expressed in multiple mouse tissues including brain, spleen, lung, kidney and testis. Full-length DDA3 cDNA was cloned and it contained an open reading frame predicted to encode a proline rich protein of 329 amino acids. Overexpression of DDA3 in H1299 lung carcinoma cells suppressed colony formation. These results suggest that DDA3 is a p53-regulated gene that might participate in the p53-mediated growth suppression.
Introduction
Alterations on the p53 tumor suppressor gene are the most common genetic changes found in human cancers of diverse types (Hollstein et al., 1991; Levine et al., 1991) . p53 elicited multiple phenotypic consequences in cells including cell cycle arrest, dierentiation, apoptosis and transformation suppression (for reviews, Gottlieb and Oren, 1996; Ko and Prives, 1996; Hansen and Oren, 1997; Levine, 1997) . Much evidence indicates that p53 acts as a guardian of genome to prevent the accumulation of genetic damages (Lane, 1992) .
Although mechanisms by which p53 elicits its eect have not been completely de®ned, one most well characterized biochemical function of p53 is its activity to modulate the transcription of genes carrying distinct p53 recognition motifs (El-Deiry et al., 1992; Farmer et al., 1992) . p53 contains distinctive domains for DNA binding and transactivation (Vogelstein and Kinzler, 1994; Ko and Prives, 1996) . More than 90% of the p53 aberrations in cancer are point mutations in its DNA binding domain (Harris, 1993) , re¯ecting that the transactivation activity of p53 is critical for its role as a tumor suppressor. It is not surprising that intensive research has been focused on the identi®cation and characterization of the p53 target genes since the products of which may involve in the tumor suppression function of p53. In line with this, substantial evidence indicates that p53 induced-G 1 arrest is, in part, due to the activation of p21 WAF1/CIP1 (El-Deiry et al., 1993; Harper et al., 1993; Deng et al., 1995) . p21 WAF1/CIP1 complexes with cyclin dependent kinases and suppresses its activity, in addition, it also binds PCNA and inhibits DNA replication (Li et al., 1994) . Bax (Miyashita and Reed, 1995) , PAG608 (Israeli et al., 1997) and IGF-BP3 (Buckbinder et al., 1995) are p53-regulated genes implicated in mediating p53-mediated apoptosis. Signi®cant advances have been made recently toward the identi®cation of potential p53 eector genes. For example, through the method of dierential display, Amson et al. (1996) have isolated ten cDNA fragments activated by p53 in myeloid leukemia cells. In addition, Polyak et al. (1997) utilizing the SAGE approach (Velculescu et al., 1995) , found a total of 14 mRNAs that are markedly increased in levels upon ectopic p53 expression. Characterization of these genes will be important in understanding the mechanisms of the p53-mediated cellular responses.
Studies have implicated p53 as a G 1 checkpoint control responding to stress conditions such as girradiation (Kuerbitz et al., 1992) , DNA damage (Kastan et al., 1991) and nucleotide depletion (Linke et al., 1996) . p53 reacts to the stress situations by stabilization (reviewed in Giaccia and and accumulating in a biochemically active form in part through post-translational modi®cation events (Banin et al., 1998; Canman et al., 1998; Woo et al., 1998) . Besides G 1 arrest, p53 has been shown to play a part in the regulation of G 2 phase progression. When cells are exposed to spindle inhibitor nocodazole, p53 7/7 cells continue to divide whereas those expressing wild type p53 are shown to arrest in G 2 /M phase of the cell cycle (Cross et al., 1995) . Hermeking et al. (1997) have demonstrated that 14-3-3-s is a direct p53 target gene which, upon overexpression, arrests cells in G 2 /M phase. In addition, a novel p53-inducible gene B99 was recently cloned that encodes a microtubulelocalized protein and is speci®cally expressed in G 2 phase of the cell cycle (Utrera et al., 1998) . These ®ndings suggest that p53 might be involved in G 2 phase progression although mechanisms of p53 in arresting G 2 phase is largely unknown.
Although many p53 target genes have been found, to this date, the molecular pathways to achieve p53 tumor suppression remain unclear. This study was undertaken to further isolate p53-regulated genes. The mRNA dierential display (Liang and Pardee, 1992) was performed on IW32 erythroleukemia cells expressing a temperature-sensitive p53 mutant cDNA, p53val-135 (Michalovitz et al., 1990) . At permissive temperature, p53val-135 assumes wild type p53 conformation and functions like wild type p53, whereas at restrictive temperature it behaves like mutant p53 and is unable to activate transcription. We now report the isolation of a cDNA, designated DDA3, that was up-regulated by wild type p53 in p53-overexpressing cells as well as in cells containing endogenous p53 activated by DNA damage. Analysis by colony inhibition assay showed that DDA3 signi®cantly decreased the number of colony formed in H1299 human non-small cell lung carcinoma cells suggesting that DDA3 could mediate, at least in part, the growth suppressive activity of p53.
Results

Identi®cation of DDA3 cDNA through dierential display
Several IW32 murine erythroleukemia cell clones stably transfected with tsp53val-135 DNA were obtained. The expression of p53 was con®rmed by Western blotting (data not shown). In all clones expressing tsp53val-135 analysed, downshifting of temperature to 32.58C induced G 1 arrest. Some clones predominantly underwent apoptosis while for others, the majority of cells underwent viable G 1 arrest and matured along the erythroid pathway. In order to identify the p53-regulated genes, we performed mRNA dierential display on clone 1 ± 5 cells cultured at 32.58C and 38.58C. Clone 1 ± 5 cells when grown at permissive temperature, arrested in G 1 phase of the cell cycle and underwent dierentiation, as indicated by increased hemoglobin mRNA and protein levels (data not shown). Upon dierential display with a total of 16 arbitrary 10-mers and three poly-primers, we have identi®ed cDNA fragments provisionally named DDA3 (as it is identi®ed by dierential display and is activated by p53) that showed increased levels of expression upon concomitant p53 induction. Sequence analysis revealed that DDA3 represented the 3'-terminal cDNA of a novel gene that did not share signi®cant homology to any published gene sequences of an updated gene bank.
Northern blot analysis was performed to verify the dierential expressed pattern of DDA3 gene. Total RNA was isolated from the parental IW32 cells as well as clone 1 ± 5 cells bearing tsp53val-135 allele grown at 38.58C, and the same cells shifted to 32.58C for various times. As shown in Figure 1a , a transcript corresponding to approximately 1.9 kb in size that was hybridized by the radio-labeled probe generated from DDA3 cDNA fragment was induced as early as 2 h in clone 1 ± 5 cells after temperature downshifting, indicating that DDA3 upregulation is a relatively early event. The maximum induction was achieved at 4 h and the DDA3 transcript remained elevated for at least 12 h at 32.58C. No DDA3 induction was observed in the parental IW32 cells, suggesting that upregulation of DDA3 was not merely a non-speci®c temperature eect. Similar pattern of induction was seen with p21 waf1/cip1 transcript. In addition to clone 1 ± 5, Northern blot analysis indicated that DDA3 up-regulation could be detected in all other IW32 sublines containing tsp53val-135 allele cultured at 32.58C (Figure 1b) , suggesting its induction is not a positional eect due to site speci®c integration of the tsp53val-135 cDNA.
Cloning of the full-length DDA3 cDNA 5'-RACE was performed to clone the full-length DDA3 cDNA. A novel cDNA of 1676 bp that contains a noninterrupted open reading frame of 990 bp was obtained (Figure 2a) . This cDNA has an upstream initiation codon starting at nucleotide 116 and an in-frame termination codon at nucleotide 1103. A 3'-untranslated region of 571 bp that contains a polyadenylation signal was followed. The ATG starting at nucleotide 116 is likely to be the translation initiation codon since it is preceded by an in-frame stop codon located 78 bp upstream and the nucleotide sequence surrounding it, GAGCATGG, resembled the consensus Kozak sequence required for optimal initiation by eucaryotic ribosomes (Kozak, 1987) . The predicted DDA3 protein contains six repeats of the sequence PXXP (where P represents proline and X any amino acid) known to (a) The parental and the tsp53val-135 bearing IW32 cells were cultured at 38.58C and then shifted to and maintained at 32.58C for the indicated times. RNA was prepared and 25 mg per lane was loaded to a 1.2% MOPS-formaldehyde-agarose gel and separated by electrophoresis. The RNA was transferred to a Hybond-N nylon membrane and hybridized with 32 P-labeled DDA3 and p21 cDNA. The same blot was also probed for GAPDH mRNA expression as an internal control. (b) Various tsp53val-135-transfected IW32 clones were cultured at 38.58C and shifted to 32.58C for 8 h, RNA was extracted and analysed for DDA3 expression by Northern blotting. The blot was also probed for GAPDH for the amount and quality of RNA loaded bind SH3 domain (Cohen et al., 1995; Pawson, 1995) . In addition, it also carries a coiled-coil domain at residues 74 ± 94, suggesting that DDA3 is capable of interacting with other proteins. DDA3 sequence also contains many consensus phosphorylation sites for protein kinase C, casein kinase II and protein kinase A. The predicted protein sequence of DDA3 reveals limited homology to known proteins with the exception of the newly cloned p53 regulated protein B99. B99 encodes a protein of 741 amino acids and was shown to be speci®cally expressed in G 2 phase of the cell cycle (Utrera et al., 1998) . Homology alignment demonstrated that DDA3 and the N-terminal 350 amino acid residues of B99 share 27% identity ( Figure  2b ).
Tissue distribution of DDA3 was examined by Northern blot hybridization of the mouse multiple tissue blot (Clontech) using DDA3 cDNA as a probe. DDA3 is abundantly expressed in the brain, spleen and lung, moderate expression was found in the kidney ( Figure 3 ).
Transcriptional regulation of DDA3
To examine the mechanisms of DDA3 up-regulation, we analysed DDA3 expression in the presence of RNA synthesis inhibitor actinomycin D. As indicated in Figure 4a , actinomycin D blocked the induction of DDA3 by p53, indicating that the induction was through transcriptional regulation. On the other hand, DDA3 induction persisted in the presence of protein synthesis inhibitor cycloheximide (Figure 4b ), suggesting that DDA3 mRNA accumulation did not require de novo protein synthesis. We next examined if elevated DDA3 transcript required the continuous presence of p53. Clone 1 ± 5 cells were incubated for 8 h at 32.58C to induce the DDA3 expression and the cells were then divided into two parts; half of the cells were shifted to 38.58C whereas the remaining half was maintained at 32.58C. At various incubation times, cells were subjected to Northern blot analysis for DDA3 expression. As shown in Figure 4c , DDA3 mRNA disappeared within 4 h upon shifting the temperature back to 38.58C. On the contrary, cells that cultured at 32.58C expressed and maintained stable levels of DDA3 mRNA throughout the time course analysed. These ®ndings demonstrated that DDA3 mRNA expression is closely associated with the expression of p53. The short half-life in the absence of p53 may imply that after transcription, DDA3 transcript is rapidly degraded through mechanisms to be determined. Interestingly, similar patterns of p53-dependent p21 waf1/cip1 mRNA expression were observed.
Induction of DDA3 by DNA damage
We next examined whether DDA3 could be induced under more physiological conditions. NIH3T3 cells which contained endogenous wild type p53 allele were treated with DNA damaging agents adriamycin (400 ng/ml) and mitomycin C (10 mg/ml) for 12 h, and DDA3 expression analysed by Northern blotting. As shown in Figure 5a , DDA3 transcripts were induced to relatively high levels following the drug treatments. The pattern of DDA3 induction is similar to that of p21 waf1/cip1
. Concomitant with the upregulation of DDA3, elevated p53 protein levels were indeed observed under these circumstances, as evidenced by Western blotting with p53 antibodies (Figure 5b ). As a control, the amount of nucleolin, which is an abundantly expressed nuclear protein (Chen et al., 1991) , was not aected by the treatments. The result that DDA3 induction was not restricted to erythroleukemia cells overexpressing p53 supports the notion that DDA3 may act as a general target of p53.
DDA3 overexpression inhibits colony formation of H1299 cells
To determine its subcellular localization, DDA3 gene was expressed as a Flag-tagged fusion protein in H1299 non-small cell lung cancer cells (null for p53) and detected with M5 FLAG-speci®c antibody by immunouorescence. As indicated in Figure 6 , the DDA3 protein appeared cytoplasmic, being mostly absent in the nucleus. The possibility that DDA3 may mediate the growth suppressing eect of p53 was next evaluated via stable transfection in a colony inhibiting assay. The pFLAG-DDA3 construct and pRc-CMV carrying the neo-resistant gene were cotransfected into H1299 cells that were then maintained in medium containing G418 and the drug-resistant colonies were scored 14 days after transfection. A representative experiment is shown in Figure 7 , which demonstrated that DDA3 signi®cantly suppressed the growth of H1299 cells. Results from three separate experiments were given which indicated that the average colony number fell to 33% relative to the FLAG control. The ability of DDA3 to suppress colony formation was, however, less potent than that of p21 waf1/cip1 whose expression virtually abolished colony formation in H1299 cells (colony number fell to 5% of control). We have also shown that wild type p53 suppressed colony number to 6% of control level while mutant p53, either p53 R175H or p53 R273H had no detectable inhibition on H1299 colony formation (data not shown). These results indicate that DDA3 by itself when overexpressed, can suppress colony formation. Discussion p53 tumor suppressor is known to involve in multiple cellular responses including cell growth arrest, apoptosis, DNA repair, and cell differentiation. One mechanism by which p53 protein exerts its eect is by transcriptional regulation of genes containing speci®c p53 recognition motifs. Thus a key approach to understand p53 function is to identify genes that are direct targets of p53 transactivation, because the products of these genes could be potential mediators of p53. In the present study, we report the cloning and characterization of a novel p53-regulated gene DDA3 from an IW32 murine erythroleukemia cell clone stably expressing a temperature sensitive allele of p53, tsp53val-135. In addition to the clone 1 ± 5 cells studied in this work, several other clones were also obtained. Some of these clones (such as clone 1 ± 5) underwent viable G 1 arrest and dierentiation with little signs of apoptosis while in other sublines (such as clone 3 ±
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Identification of a novel mouse p53 target gene DDA3 P-K Lo et al 2), the vast-majority of cells died after initial G 1 arrest. Signi®cantly, prominent DDA3 induction was found in all of the tsp53val-135 sublines examined, irrespective of the cellular consequences the wild type p53 elicited in them. Conspicuous up-regulation of DDA3 mRNA was also observed in NIH3T3 cells treated with DNA damaging agents such as adriamycin and mitomycin C, suggesting that the induction of DDA3 would occur under more physiological conditions as a downstream event of the endogenous wild type p53. The fact that DDA3 induction was detected in more than one type of cell through dierent mechanisms of p53 activation support the notion that DDA3 is likely to be a general downstream target of p53. DDA3 gene expression is intimately coupled to wild type p53 expression. Analysis on the kinetics of its induction in tsp53val-135 transfectants indicated that DDA3 activation was rapid and robust upon temperature downshift and its transcript levels reached plateau within 4 h and remained elevated as long as the cells were kept as permissive temperature. Upon shifting back to the restrictive temperature, the transcript promptly degraded with a half-life of less than 2 h. Similar activation and degradation kinetics were observed for p21 waf1/cip1 mRNA, the prominent downstream target gene of p53. These results suggest that both DDA3 and p21 waf1/cip1 transcripts undergo rapid turnover and are therefore dependent on the continuous presence of the wild type p53 for synthesis. The p53 dependent activation of DDA3 expression is abolished by transcription inhibitor actinomycin D, but not by protein synthesis inhibitor cycloheximide, suggesting that p53 modulates DDA3 expression through transcriptional regulation, and the induction of DDA3 mRNA does not require de novo protein synthesis. This conclusion is further supported by the presence of a consensus p53 recognition motif located in intron 3 of the DDA3 genome. Analysis by gel retardation indicates that p53 binds to the consensus motif derived from DDA3 intronic sequences, furthermore, the complex formed could be supershifted by p53 speci®c antibody. We also demonstrated by transient transfection assay that this sequence conferred the p53 responsiveness when cloned upstream to a reporter gene containing a minimal promoter (manuscript in preparation). These ®ndings, along with the work presented here, strongly demonstrate that DDA3 is a direct transcriptional target of p53.
We have shown that DDA3 overexpression decreased the number of drug-resistant colonies of H1299 cells by stable transfection in a colony inhibition assay. Although it is not clear if expression of DDA3 elicits predominantly cell growth arrest or apoptosis, in any event, the biological signi®cance of p53-mediated-DDA3 induction remains to be determined. In both systems we studied, IW32 erythroleukemia sublines containing tsp53val-135 allele as well as NIH3T3 cells, transactivation of DDA3 was observed in parallel to that of p21 waf1/cip1 , a better known p53 target gene which has been demonstrated by others, to be involved in p53 mediated growth suppression (Waldman et al., 1995; Polyak et al., 1996) . In colony inhibition assay, we have also shown that DDA3 exerts similar eect, albeit to a lesser degree, to suppress the growth of H1299 cells, as p21
. Thus the induction of DDA3 may appear to be redundant in mediating the growth suppressing eect of p53, from this point of view, DDA3 may have another yet to be de®ned function. However, recent evidence suggests that it is (7) actinomycin D (AcD, 5 mg/ml) for 30 min, cells were then cultured at 32.58C for 4 h. RNA was extracted and analysed by Northern blotting for DDA3 expression. The same blot was probed for GAPDH as a RNA loading control. (b) The parental (IW32) and clone 1 ± 5 cells were treated in the presence (+) or absence (7) of 10 mg/ml of cycloheximide (CHX) for 1 h. Cells were then cultured at 32.58C for 4 h. RNA was extracted and analysed by Northern blotting for DDA3 and GAPDH expression. (c) Clone 1 ± 5 cells were cultured at 32.58C for 8 h, at the end of the incubation, cells were divided into two parts. Half of the cells were incubated at 38.58C, and the second half maintained at 32.58C. After incubation for the indicated times, RNA was prepared and analysed for both DDA3 and p21 waf1/cip1 mRNA expression. The expression of GAPDH is shown as an internal loading control rather unlikely for a single target protein to be by itself eciently mediates the growth suppressive function of p53 (Chen et al., 1996; Polyak et al., 1997; Wyllie, 1997) . It is reasonable to speculate that many targetgene products together with the p53 associated proteins, may work in a coordinated fashion to mediate the multiple p53-dependent responses.
Sequence analysis of DDA3 reveals that up to 13% of its amino acids are proline residues. We have demonstrated that DDA3 shares limited homology with B99, a p53-inducible gene recently cloned by Utrera et al. (1998) . There are 27% identities and close to 50% similarities between the N-terminal 350 amino acid residues of B99 and the deduced amino acid sequence of DDA3. B99 encodes a proline-rich protein of 741 amino acids that co-localized with tubulin to the microtubule network. Moreover, it is speci®cally expressed in G 2 phase and its overexpression increased the fraction of cells in G 2 . The ®nding that two p53 regulated genes both contain homologous proline-rich region suggest the signi®cance of this domain in p53 downstream signaling.
We have noted that DDA3 contains six repeats of the sequence PXXP, this motif has been shown to play a role in signal transduction by interacting with SH3 domain containing proteins (Feller et al., 1994; Cohen et al., 1995) . The SH3 domains are found in a variety of proteins with important roles in growth factor and cytokine signaling (Schlessinger, 1994; Birge et al., 1996) . It is tempting to speculate that DDA3 may interfere with growth factor-or stress-mediated signal transduction pathways by interacting with SH3 containing molecules. In line with this, DDA3 also contains many potential phosphorylation sites including those for casine kinase II, PKA and PKC, indicating the possibility that the function of DDA3 could be modulated by kinases through phosphorylation. It is conceivable that DDA3 may act as an important component in linking p53 to the intracellular components of the signal transduction apparatus. Identi®cation of proteins capable of speci®cally interacting with DDA3 will greatly increase our understanding of the p53-signaling network. Interestingly, the human p53 protein also contains ®ve repeats of PXXP in the proline rich domain encompassing amino acids 61 to 94 (Walker and Levine, 1996) . It has been shown that this domain participates in the sequence speci®c transactivation of apoptosis related genes such PIG3 and repression of promoters by p53 (Venot et al., 1998) . The proline rich domain has been Figure 5 (a) Induction of DDA3 mRNA expression in NIH3T3 cells in response to DNA damaging agents. NIH3T3 cells were incubated in the presence of adriamycin (AD, 400 ng/ml) or mitomycin C (MC, 10 mg/ml) for 12 h, respectively. RNA was prepared and analysed for DDA3 and p21 waf1/cip1 expression. Control lane (C) represents cells mock-treated with ethanol (carrier for adriamycin and mitomycin C). (b) NIH3T3 cells were treated as indicated, after 12 h, nuclear extracts were prepared and separated by 10% SDS ± PAGE. The proteins were transferred to a nitrocellulose membrane and reacted with antibodies speci®c for p53 and nucleolin, immuno-reactive-bands were detected by ECL reagents a b Figure 6 Subcellular localization of DDA3 in transiently transfected cells. Non-small cell lung cancer H1299 cells were transiently transfected with pFLAG-DDA3 (b) or its vector control pFLAG-CMV2 (a) and incubated at 378C for 2 days. Cells were ®xed and reacted with M5 anti-FLAG monoclonal antibody followed by FITC coupled goat anti-mouse IgG and viewed under a¯uorescence microscope (Nikon Eclipse E800)
shown to be necessary for ecient growth suppression of p53, due for the most part, to its mediation in apoptosis (Walker and Levine, 1996; Venot et al., 1998) . The ®nding that p53 and DDA3 both contain multiple copies of PXXP strengthens the possibility that interactions between p53 and its target protein with SH3 containing components of the cellular signaling network may be important in mediating the growth suppression eect of p53.
In conclusion, we have reported the identi®cation and cloning of DDA3 as a possible transcriptional target of p53, and shown that overexpression of DDA3 inhibits colony formation. Although the biological signi®cance of DDA3 induction remains to be elucidated, nevertheless, the ®nding that conspicuous induction of DDA3 could be observed in DNA damage induced NIH3T3 cells implies that DDA3 could be a general p53 downstream molecule. Further analysis on the signi®cance of DDA3 activation should provide a better insight on the pathways mediating the tumor suppressor function of p53.
Materials and methods
Cell culture
IW32 murine erythroleukemia cells were maintained in RPMI medium containing 10% fetal bovine serum (FBS) and 50 mg/ ml of gentamycin in 5% CO 2 (Choppin et al., 1984) . Cells were co-transfected with tsp53val-135 cDNA and pRSV-neo, and plated in medium containing methylcellulose. One day after transfection, they were selected in 0.5 mg/ml G418 for 3 weeks, single colonies were isolated and p53val-135 expression con®rmed by Western blotting. Temperature-shifting was performed by transferring subcon¯uent cells to the preequilibrated incubator at 32.58C. Mouse NIH3T3 ®broblast cells were grown in DMEM containing 10% calf serum, 100 U/ml of penicillin and 100 mg/ml of streptomycin in 5% CO 2 at 378C, with cells subcultured every 3 days. To activate the expression of endogenous p53, cells were grown to 80% con¯uence and then treated with adriamycin (400 ng/ml) or mitomycin C (10 mg/ml) for 12 h (Woo et al., 1998) .
mRNA dierential display
Total RNA was isolated by lysing the cells in Tri-reagent (Molecular Research Center, INC.) according to the manufacturer's instructions. The RNAimage kit from GenHunter was used for mRNA dierential display. RNA isolated from IW32 parental and clone 1 ± 5 cells cultured at 0, 5 and 9 h after temperature shifted to 32.58C was treated with 20 U of RNase-free DNase I (Promega) at 378C for 30 min, extracted with phenol/chloroform twice and chloroform once, and precipitated with ethanol. The RNA (0.4 mg) was suspended in DEPC-treated H 2 O, and incubated with 100 U of M-MuLV reverse transcriptase, 40 U RNasin, and 0.2 mM H-T11G (A or C) primer in 20 ml of buer (25 mM Tris-HCl, pH 8.3, 37.6 mM KCl, 1.5 mM MgCl 2 , 5 mM DTT and 20 mM dNTP) at 378C for 1 h. After heat inactivation of the reverse transcriptase at 758C for 5 min, 2 ml of the sample was used for PCR in 20 ml of PCR buer (10 mM Tris-HCl, pH 8.4, 50 mM KCl, 1.5 mM MgCl 2 , 0.001% gelatin and 2 mM dNTP) with 0.2 mM arbitrary primer (H-AP1*16), 0.2 mM H-T11G (A or C) primer, 1 ml of [a-35 S]dATP (1000 Ci/mmol) and 1 U AmpliTaq polymerase (PerkinElmer). The parameters for PCR were as follows: 40 cycles of cycling step (948C for 30 s, 408C for 2 min, 728C for 30 s) followed by 728C elongation step for 5 min. The ampli®ed cDNAs were separated on 6% sequencing gel. The dierentially expressed bands were excised from the dried gel, boiled in 100 ml of H 2 O for 15 min, precipitated with ethanol and suspended in 10 ml of H 2 O. Four ml of recovered cDNAs were used for re-ampli®cation by PCR in 40 ml of PCR reaction buer with the same primers and conditions used for initial ampli®cation except that a higher concentration of dNTP (20 mM) was used. Re-ampli®ed cDNAs were puri®ed with agarose gel and directly ligated into pGEM-T TA cloning vector (Promega) for sequencing.
Cloning of mouse DDA3 cDNA
To clone the dierentially expressed cDNA fragment DDA3, the Marathon cDNA Ampli®cation kit (Clontech) was adopted using RNA prepared from IW32 erythroleukemia cells containing stably expressed tsp53val-135 (clone 1 ± 5) cultured at 32.58C. For the ®rst strand cDNA synthesis, 1 mg of the poly(A) + RNA from clone 1 ± 5 cells was incubated with 100 units of M-MuLV reverse transcriptase and 10 pmol of oligo-dT primer in 10 ml of 50 mM Tris, pH 8.3 containing 6 mM MgCl 2 , 75 mM KCl, and 1 mM dNTP for 1 h at 428C. After that a mixture of enzymes containing DNA polymerase I (24 units), DNA ligase (4.8 units) and RNase H (1 unit) was added, and the reaction was carried out in 80 ml ®nal volume of 100 mM KCl, 10 mM ammonium sulfate, 5 mM MgCl 2 , 0.15 M b-NAD, 0.2 mM dNTP in 20 mM Tris-HCl, pH 7.5 at 168C for 45 min. The double strand cDNA was puri®ed and ligated with the cDNA adaptor according to the protocol recommended by the manufacturer. The 5'-RACE reaction utilized a DDA3-speci®c antisense primer 5'-CTCCTGGCCTTTCCAAACAGACC-3', designed from the DDA3 cDNA fragment (1536 ± 1558, Figure 2a) , in conjunction with adaptor primer AP1. RACE products were puri®ed with agarose gel and cloned into pGEM-T vector. A total of 12 clones were selected for autosequencing analysis and the longest one with correct sequence (pGEM-T-DDA3-3) containing 1558 bp was selected for further analysis. All homology searches and multiple sequence alignments were performed using the Genetics Computer Groups software programs (University of Wisconsin, WI, USA).
Northern blot analysis
For Northern blotting, 25 mg of total RNA was separated by electrophoresis in 1.2% MOPS-formaldehyde-agarose gel. RNA was then blotted to the Hybond-N nylon membrane Figure 7 Overexpression of DDA3 inhibits colony formation of non-small cell lung cancer H1299 cells. H1299 cells (8610 3 cells) were plated in 6 cm culture dish for 24 h and incubated at 378C. For transfection, 2 mg each of pFLAG-CMV2, pFLAG-DDA3 or pFLAG-p21 was cotransfected with 0.2 mg of Neo-resistant construct pRc-CMV (Invitrogen) using the lipofectamine PLUS reagents (Gibco-BRL) according to the protocols provided. After 24 h, cells were cultured in the presence of 0.5 mg/ml of G418, and medium was changed every 3 days. The G418-resistant colonies were scored at day 14 after ®xing and staining with crystal violet (1 mg/ml). The average of colony numbers obtained from three independent transfection experiments, each performed in triplicate are shown (Amersham) by capillary transfer. The blot was then hybridized to the 32 P-labeled cDNA.
Preparation of nuclear extract and immunoblot analysis
Nuclear extract was prepared according to the protocols described by McLure and Lee, (1998) . About 5610 6 cells were washed in ice cold PBS, and lysed in 100 ml of ice-cold hypotonic solution (10 mM HEPES, 10 mM KCl, 1 mM Mg(OAc) 2 , 1 mM DTT, 10% glycerol, and 1 mM PMSF) for 10 min. The mixture was centrifuged at 12 000 g for 5 min and the pellet was extracted with 40 ml hypertonic solution (hypotonic solution containing 0.5 M KCl) with continuous agitation for 30 min. After centrifuging at 12 000 g for 5 min, the supernatant containing the nuclear extract was analysed for p53 expression. For immunoblot analysis, about 40 mg of the nuclear protein was separated by 10% SDS ± PAGE, the proteins were electro-blotted to a nitrocellulose paper. It was ®rst incubated with p53 speci®c antibody (Ab-1) (Calbiochem) for 2 h at 258C followed by reacting with goat anti-mouse antibody. The immunoreactive proteins were detected by the ECL reagents.
Immuno¯uorescence staining H1299 cells were plated on glass coverslips (1610 4 per cm 2 ). After washing with PBS, cells were ®xed with 2% formaldehyde in PBS for 20 min at 258C followed by cold acetone (7208C) for 5 min and washed with Tris-saline (20 mM Tris-HCl containing 0.8 mM CaCl 2 . 1 mM MgCl 2 and 0.15 M NaCl, pH 7.4). The FLAG-tagged DDA3 was detected with the M5 monoclonal antibody against FLAG (Kodak) at 378C for 60 min followed three washes of Trissaline and ®nally by reacting with goat anti mouse¯uorescein isothiocyanate (FITC)-conjugated antibody at 378C for 30 min. After extensive washes in Tris-saline, the cells were dehydrated sequentially with 70 and 95% ethanol, and examined under a¯uorescence microscope (Nikon Eclipse E800).
Colony formation assay
DDA3 cDNA encompassing nucleotides 112 to 1214 that contains the complete ORF was synthesized by PCR using pGEM-T-DDA3-3 as template. After puri®cation, it was ligated to pFLAG-CMV-2 (Kodak), and the pFLAG-DDA3 sequence con®rmed by auto-sequencing. Mouse p21 cDNA contains the entire ORF was obtained by RT ± PCR using RNA prepared from clone 1 ± 5 as template. The ampli®ed p21 cDNA was ligated to pFLAG-CMV-2. For transfection, H1299 human non-small cell lung cancer cells (8610   3   ) were seeded in a 6.0 cm culture dish for 24 h in RPMI 1640 containing 10% FBS, then 2 mg of DNA to be introduced, including pFLAG-CMV-2, pFLAG-DDA3 and pFLAG-p21, was mixed with 0.2 mg of the Neo-resistant plasmid vector pRc-CMV (invitrogen), and transfected to cells using the lipofectamine PLUS reagent and according to the protocols provided by the manufacturer (Gibco-BRL). After 24 h, the medium was replaced with 10% FBS in RPMI 1640 containing 0.5 mg/ml of geneticin (G418). Colonies were stained with crystal violet (1 mg/ml) and scored at 14 days after transfection.
